Payment overview · 2025
General Payments
$41,946.74
22 reported records · 1 companies
Healthcare provider profile · identity verified
Farid A Ahmad, MD
Allopathic & Osteopathic Physicians|Family Medicine · OAK CREEK, WI · NPI 1871916031
Verified facts
What the public records show
CMS Open Payments records show Farid A Ahmad, MD received $41,946.74 in general payments during 2025 across 22 reported records.
Takeda Pharmaceuticals U.S.A., Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $41,946.74 | 100.0% | 22 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $41,946.74 | 22 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 469 | 68 |
| Atorvastatin Calcium | Atorvastatin Calcium | 359 | 103 |
| Furosemide | Furosemide | 355 | 79 |
| Levothyroxine Sodium | Levothyroxine Sodium | 330 | 47 |
| Gabapentin | Gabapentin | 215 | 60 |
| Sertraline Hcl | Sertraline Hcl | 202 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 174 | 45 |
| Quetiapine Fumarate | Quetiapine Fumarate | 160 | 47 |
| Amlodipine Besylate | Amlodipine Besylate | 155 | 50 |
| Metoprolol Tartrate | Metoprolol Tartrate | 129 | 33 |
| Metformin Hcl | Metformin Hcl | 122 | 30 |
| Trazodone Hcl | Trazodone Hcl | 119 | 35 |
| Divalproex Sodium | Divalproex Sodium | 118 | 26 |
| Potassium Chloride | Potassium Chloride | 112 | 29 |
| Levetiracetam | Levetiracetam | 111 | 22 |
| Baclofen | Baclofen | 108 | 20 |
| Losartan Potassium | Losartan Potassium | 98 | 25 |
| Lubiprostone | Lubiprostone | 98 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 90 | 34 |
| Omeprazole | Omeprazole | 82 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 81 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 81 | 29 |
| Warfarin Sodium | Warfarin Sodium | 78 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 75 | 18 |
| Jardiance | Empagliflozin | 73 | 13 |
| Midodrine Hcl | Midodrine Hcl | 72 | 24 |
| Buspirone Hcl | Buspirone Hcl | 70 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 69 | 43 |
| Donepezil Hcl | Donepezil Hcl | 64 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 62 | 22 |
| Olanzapine | Olanzapine | 62 | 13 |
| Lisinopril | Lisinopril | 60 | 22 |
| Metoclopramide Hcl | Metoclopramide Hcl | 58 | suppressed |
| Bumetanide | Bumetanide | 57 | 11 |
| Mirtazapine | Mirtazapine | 56 | 22 |
| Simvastatin | Simvastatin | 56 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 55 | 21 |
| Memantine Hcl | Memantine Hcl | 52 | suppressed |
| Carvedilol | Carvedilol | 51 | 17 |
| Spironolactone | Spironolactone | 51 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 50 | 16 |
| Aripiprazole | Aripiprazole | 49 | 13 |
| Montelukast Sodium | Montelukast Sodium | 46 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 44 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 43 | 21 |
| Risperidone | Risperidone | 43 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 42 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 41 | 34 |
| Scopolamine | Scopolamine | 41 | suppressed |
| Famotidine | Famotidine | 40 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 38 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | suppressed |
| Lamotrigine | Lamotrigine | 38 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Entresto | Sacubitril/Valsartan | 34 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 34 | suppressed |
| Finasteride | Finasteride | 32 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 32 | 15 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 32 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 31 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 23 |
| Januvia | Sitagliptin Phosphate | 28 | suppressed |
| Topiramate | Topiramate | 28 | suppressed |
| Lorazepam | Lorazepam | 27 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 26 | 16 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 26 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 20 |
| Sodium Chloride | 0.9 % Sodium Chloride | 25 | 13 |
| Albuterol Sulfate | Albuterol Sulfate | 24 | 15 |
| Allopurinol | Allopurinol | 24 | suppressed |
| Cephalexin | Cephalexin | 24 | 15 |
| Prednisone | Prednisone | 23 | 13 |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 22 | 14 |
| Santyl | Collagenase Clostridium Hist. | 22 | 12 |
| Tramadol Hcl | Tramadol Hcl | 22 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 21 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 14 |
| Venlafaxine Hcl | Venlafaxine Hcl | 21 | suppressed |
| Azithromycin | Azithromycin | 20 | 13 |
| Benztropine Mesylate | Benztropine Mesylate | 20 | suppressed |
| Lacosamide | Lacosamide | 20 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 19 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 19 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 16 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Lactulose | Lactulose | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Ozempic | Semaglutide | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Xarelto | Rivaroxaban | 17 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 16 |
| Nystatin | Nystatin | 16 | 13 |
| Atenolol | Atenolol | 15 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Carbamazepine Er | Carbamazepine | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 15 | suppressed |
| Nystop | Nystatin | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 14 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $41,946.74 · 22 records | Takeda Pharmaceuticals U.S.A., Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error